Immune

Thymogen

Also known as: EW Dipeptide, Glu-Trp, L-Glutamyl-L-Tryptophan, Oglufanide

Clinical Trials
Share:

Popular For

Immune modulation, T-cell support, immune aging

Key Facts: Thymogen

Category
Immune
FDA Status
Not FDA Approved
Clinical Status
Approved in Russia - Clinical use for immunomodulation
Administration
Oral capsules, also available as nasal spray in some regions
Typical Dose
1-2 capsules (10-20 mg) daily
Frequency
1-2x daily, before meals
Evidence Level
Human Trials
Duration
30-day courses with 2-3 month breaks
Also Known As
EW Dipeptide, Glu-Trp, L-Glutamyl-L-Tryptophan, Oglufanide

Mechanism of Action

Thymogen (alpha-glutamyl-tryptophan) stimulates cellular factors of immunogenesis, promotes proliferation and differentiation of T-lymphocyte precursors into mature immunocompetent cells. It normalizes the ratio of T-helpers to T-suppressors, increases cyclic adenosine monophosphate (cAMP) in T-lymphocyte precursors, and modulates immune cell maturation. Pharmacokinetic studies show rapid tissue uptake, particularly in liver, adrenals, kidney, lymph nodes, and thymus.

Research Summary

Originally isolated from Thymalin via reversed-phase HPLC, then synthesized. Clinical studies in Russia show immunomodulatory effects including normalization of T-cell subsets. Animal studies demonstrate geroprotective activity - Thymogen administration in rats led to increased survival and 1.5-fold decrease in tumor development. Has been used clinically for over 20 years as an immunomodulator.

Clinical Status:Approved in Russia - Clinical use for immunomodulation
Trial Progress:Preclinical
Pre
I
II
III
IV
FDA

Dosing Information

Human Trials·Clinical use in Russia, human studies conducted

Typical Dosing

Community experience

Common Dose

1-2 capsules (10-20 mg) daily

Range

10-20 mg per day

Frequency

1-2x daily, before meals

Khavinson bioregulator with decades of clinical use in Russia. Often used in 30-day cycles with breaks between courses. May be combined with other thymus peptides like Vilon or Thymalin.

Research Dosing

Scientific studies

Khavinson bioregulator dosing - clinically used in Russia

Duration

30-day courses with 2-3 month breaks

Administration

Oral capsules, also available as nasal spray in some regions

Timing & Administration

Best Time to Take

Morning, before meals

1-2 times daily

Food Recommendation

With or without food

Why This Timing?

Immune function peptides often taken morning to support daytime immune activity.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

  • Generally well-tolerated
  • No significant side effects reported in clinical use
  • Rare allergic reactions possible
  • Individual intolerance to components

References

Related Peptides

Peptides commonly compared with Thymogen or used in similar applications.

Looking for a trusted vendor?

Pro members get access to verified vendors with quality standards & exclusive discount codes.

View Verified Vendors
PRO

Want updates on Thymogen research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Educational Information Only

This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.